On April 23, 2025, Medlander (688273.SH) released its Q1 2025 financial report. The company's operating revenue was 118 million yuan, representing a year-on-year increase of 13.36%; net profit attributable to shareholders was 39.8597 million yuan, up 9.85% year-on-year; non-recurring net profit attributable to shareholders was 37.5820 million yuan, increasing by 11.60% year-on-year; basic earnings per share were 0.41 yuan.
It is reported that MedlanderIn 2024, revenue reached 425 million yuan, a year-on-year increase of 24.57%; net profit attributable to parent company was 102 million yuan, a year-on-year increase of 13.75%. Among them,Pelvic Floor Rehabilitation ProductsAchieved revenue of 167 million yuan, a year-on-year increase of 3.02%, with a gross profit margin of 68.56%;Reproductive RehabilitationThe product achieved revenue of 110 million yuan, a year-on-year increase of 126.56%, with a gross profit margin of 79.34%.Medlander asChina Intelligent Pelvic Floor Reproductive Rehabilitation Diagnosis and TreatmentThe leading brand in the industry, focusing onPelvic Floor Treatment DeviceResearch and development, production, sales and service, while providingFemale Reproductive Anti-AgingOverall solution in the field.Main products include biofeedback stimulators, pelvic floor ultrasound, magnetic stimulators, high-frequency evaluation and electrocautery devices, pelvic floor trainers, portable postpartum recovery devices, home-use pelvic floor rehabilitation therapy devices, biofeedback stimulators, high-frequency evaluation and electrocautery devices, ultrasonic uterus restoration devices, electro-ultrasound therapy devices, Melander.3D Skin Analyzer, Portable Handheld Skin Tester, Finger Joint Rehabilitation Assessment System, Portable Hand Function Rehabilitation Assessment System, Hand Function Magnetic Stimulation System, Biofeedback Stimulator, Portable Biofeedback Stimulator, Vaginal Electrode, Rectal Electrode, Vaginal Probe, etc.In terms of consumer healthcare, the company actively expands its presence in home-use products.Medical Devices and Anti-Aging Field, offering private testing + anti-aging, reproductive + facial integrated solutions to meet the health and beauty needs of women, and has successively invested inYisu Medical, Aotong Laser, Xiaofu Technology, the layout of medical beauty products has been completed, preliminarily finishing the strategic planning for health and beauty, laying a foundation for the medium and long-term development of the company.
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Medlander Medical Technology Inc. was founded inIn 2013, Medlander Medical Technology Inc. was established as a provider of physical rehabilitation intervention technology solutions for the full life cycle of women in China. The company is mainly engaged in the research, development, production, and sales of products related to pelvic floor and postpartum rehabilitation, forming a series of medical pelvic floor, postpartum recovery, and home-use products. It has successively been recognized as a national specialized, refined, distinctive, and innovative "little giant" enterprise, a demonstration enterprise of a single product champion in national manufacturing, and successfully listed on the STAR Market on August 11, 2022, with the stock code: 688273.MedlanderMedlanderBuilding on the foundation of pelvic floor and postpartum rehabilitation, the company further expands into fields such as reproductive rehabilitation, sports rehabilitation, nutrition, and health management, striving to become a world-class healthcare company dedicated to women's health and beauty.It now has product lines including pelvic floor and postpartum rehabilitation equipment, reproductive rehabilitation equipment, consumables and accessories, health management information systems, etc., which are widely used in medical and health fields such as obstetrics and gynecology, pelvic floor rehabilitation, reproductive rehabilitation, urology and proctology, and physical examination.In the field of postpartum rehabilitation, mainly targeting gynecological and obstetric rehabilitation, postpartum recovery, and the diagnosis and treatment of pelvic floor functional disorders. The products mainly include: biofeedback stimulators, pelvic floor ultrasound, magnetic stimulators, high-frequency evaluation and electrocautery devices, pelvic floor training devices, portable postpartum recovery devices, and home-use pelvic floor rehabilitation therapy devices, which are widely used in departments such as gynecology, pelvic floor rehabilitation centers, urology, and proctology in hospitals.In the field of reproductive rehabilitation, mainly for the adjuvant treatment of post-abortion surgery, post-hysteroscopic surgery, infertility, premature ovarian failure, etc. The products mainly include: biofeedback stimulators, high-frequency evaluation and electrocautery devices, ultrasonic uterine involution devices, electro-ultrasound therapy devices, etc., applied in gynecology, obstetrics, reproductive centers of hospitals, medical cosmetology institutions, and other fields.In the field of sports rehabilitation, mainly targeting motor function disorders and hand function assessment and rehabilitation for people with cerebral palsy and post-stroke. Products mainly include: Finger Joint Rehabilitation Assessment System, Portable Hand Function Rehabilitation Assessment System, Hand Function Magnetic Stimulation System, Biofeedback Stimulator, Portable Biofeedback Stimulator, applied in rehabilitation departments, pediatric rehabilitation departments, neurology departments, orthopedic departments, and geriatric departments.In addition, Medlander has also strengthened the competitiveness of its rehabilitation product line through mergers, acquisitions, and investments.Horizontal Layout in Other Medical Aesthetics TracksSince 2019, investments have been made successively.Opex, Yisu Medical, Aotong Laser, Xiaofu Technology, layout of injection molded parts, female reproductive rehabilitation products, laser equipment, and technology-based skin testing, laying the foundation for long-term health and beauty strategic planning.On October 24, 2023, Medlander completed the acquisition of 100% equity in Shanghai Aotong Laser.It is reported that Aotong Laser is a high-tech enterprise specializing in the development, production, and operation of laser medical equipment. It is committed to providing users across China and other regions worldwide with comprehensive laser, photon medical, and beauty solutions, including high-performance equipment, full technical support, and continuous clinical support.On January 26, 2024, Medlander completed the acquisition of 55% equity in Hangzhou Xiaofu Technology.It is reported that Xiaofu Technology is a company that has taken the lead in completing the deep integration of imaging acquisition hardware, application software, underlying analysis algorithms, and business scenarios in the fields of 3D facial modeling and AI skin and morphology analysis. It provides customers with integrated medical aesthetics digital diagnosis and solutions. Its core product, "Meiji 3D Skin Analyzer," now serves more than 1,200 leading medical aesthetic institutions across China.On June 6, 2024, Medlander Medical Technology Inc. completed the overall structural construction of its headquarters R&D and production base project, achieving the topping out of the main structure.It is reported that the headquarters R&D and production base of Medlander officially commenced construction on December 31, 2022. Covering an area of 44 mu, with a total construction area of 90,000 square meters and a total investment of over 500 million yuan, the park integrates R&D, production, assembly, debugging, warehousing, office, and living facilities.July 5, 2024Medlander &Beautiful Landscapes Medical Technology Inc. Signs Strategic Cooperation AgreementThe two parties will join hands to deepen cooperation in sharing R&D resources for female gynecological anti-aging, jointly promoting the industry to advance to a higher level. It is reported that the two partiesWill share gynecological anti-aging research achievements, technologies, and market information, promote industry technological innovation and industrial upgrading, and provide female customers with more professional and personalized solutions.On February 28, 2025, Medlander's self-developed Class II "Ultrasonic Therapy Device" was officially approved by the Jiangsu Provincial Medical Products Administration., Registration Certificate No.: Su Medical Device Registration Approval 20252090332According to reports, as of now, two Class II ultrasound therapy devices for "skin tightening, lifting, and wrinkle removal" have been approved in China.Exclusively distributed by Jingyan BiotechMFU pro"MeramayUltrasonic Scalpel(HN Medical Device Registration No. 20242090073) andGuizhou Polida MedicalBolidaPerida®"Platinum Ultrasound Cannon"(Qian Medical Device Registration Approval 20242090048),Medlander's "Ultrasonic Therapy Device" is approved in China.The 3rd-Generation Ultrasound Therapy Device for Medical Aesthetics with Compliant Indications。
On February 26, 2025, Medlander released its 2024 earnings report. The company's total operating revenue was 423 million yuan, a year-on-year increase of 24.02%; operating profit was 113 million yuan, a year-on-year increase of 10.06%; total profit was 123 million yuan, a year-on-year increase of 21.66%; net profit attributable to shareholders was 102 million yuan, a year-on-year increase of 13.75%.
On March 12, 2025, Medlander's reproductive anti-aging brand Weizhilan®Strategic Cooperation Release Conference with Yuansong Group Held at Yuansong Medical Aesthetics in Chengdu, with Unveiling Ceremony"Chengdu Yuansong Research and Training Benchmark Base", marking the private medical aesthetics industry from"Technological Iteration" Enters a New Phase of "Ecosystem Co-construction".
